AU2025203770A1 — Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
Assigned to Xeris Pharmaceuticals Inc · Expires 2025-06-19 · 1y expired
What this patent protects
#$%^&*AU2025203770A120250619.pdf##### Abstract The present invention concerns the use of aprotic polar solvents, water and an ionization stabilization agent to prepare device compatible stable therapeutic formulations by dissolving therapeutic agent in an aprotic polar sys…
USPTO Abstract
#$%^&*AU2025203770A120250619.pdf##### Abstract The present invention concerns the use of aprotic polar solvents, water and an ionization stabilization agent to prepare device compatible stable therapeutic formulations by dissolving therapeutic agent in an aprotic polar system that can be used with devices for administration.
Drugs covered by this patent
- Kengreal (CANGRELOR) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.